TRACE-ELEMENT ANALYSES OF DIASPIRIN CROSS-LINKED HEMOGLOBIN-SOLUTIONS

被引:5
|
作者
MARSHALL, T
WELTZER, J
HAI, T
ESTEP, T
FARMER, M
机构
[1] Blood Substitutes Program, Baxter Healthcare Corporation
关键词
D O I
10.3109/10731199209119668
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A sensitive assay using inductively coupled plasma atomic emission spectroscopy (ICP-AES) has been applied to the measurement of trace elements in diaspirin cross-linked hemoglobin (DCLHb) solutions. Calcium, magnesium, zinc and iron were the only elements detected at greater than background levels. Ag, Al, As, B, Ba, Bi, Cd, Co, Cr, Cu, Mn, Mo, Pb, Sb, Se, Si, Sr, Ti, and V were present at concentrations either equal to the acid blanks or were not detected. Detection of non-heme iron (not incorporated into the hemoglobin porphyrin ring) in a 10 g/dL hemoglobin solution required the development of a special protocol. In this protocol a chelator, DTPA, was added to hemoglobin solutions to complex with both free and non-specifically bound non-heme iron. The resulting iron:DTPA complexes were separated from the hemoglobin molecules by ultrafiltration and the ultra-filtrate analyzed by ICP-AES. A modification of this assay in which the DTPA was omitted was used to measure the free non-heme iron in solution. Typical concentrations of chelatable (free and non-specifically bound) and solution (free) non-heme iron in DCLHb production lots at the completion of manufacture were 0.5-1.0 ppm and 0.1-0.3 ppm, respectively.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 50 条
  • [1] IMMUNOGENICITY OF DIASPIRIN CROSS-LINKED HUMAN HEMOGLOBIN-SOLUTIONS
    ESTEP, TN
    GONDER, J
    BORNSTEIN, I
    AONO, F
    BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4): : 603 - 609
  • [2] PREPARATION AND CHARACTERIZATION OF DIASPIRIN CROSS-LINKED HEMOGLOBIN-SOLUTIONS FOR PRECLINICAL STUDIES
    NELSON, D
    AZARI, M
    BROWN, R
    BURHOP, K
    BUSH, S
    CATARELLO, J
    CHUANG, H
    DOWNING, C
    ESTEP, T
    LOEWEN, A
    MCCLURE, K
    MCDANIEL, A
    MICHALEK, E
    MOZIER, N
    ROHN, K
    SPICUZZA, J
    ZIESKE, P
    ZIMMERMAN, G
    BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4): : 423 - 427
  • [3] PREPARATION AND CHARACTERIZATION OF CROSS-LINKED AND POLYMERIZED HEMOGLOBIN-SOLUTIONS
    BAKKER, JC
    BERBERS, GAM
    BLEEKER, WK
    DENBOER, PJ
    BIESSELS, PTM
    BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4): : 233 - 241
  • [4] The effects of diaspirin cross-linked hemoglobin in sepsis
    Mourelatos, MG
    Enzer, N
    Ferguson, JL
    Rypins, EB
    Burhop, KE
    Law, WR
    SHOCK, 1996, 5 (02): : 141 - 148
  • [5] DIASPIRIN CROSS-LINKED HEMOGLOBIN (DCLHB(TM)) POLYMERIZATION
    HAI, TT
    NELSON, D
    PEREIRA, D
    SRNAK, A
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (03): : 923 - 931
  • [6] The effect of diaspirin cross-linked hemoglobin on methemoglobin levels
    OHara, JF
    Tetzlaff, JE
    Connors, DF
    Jones, EH
    Bedocs, NM
    Schubert, A
    ANESTHESIOLOGY, 1997, 87 (03) : A205 - A205
  • [7] Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans
    Patel, MJ
    Webb, EJ
    Shelbourn, TE
    Mattia-Goldberg, C
    George, AJT
    Zhang, F
    Moore, EG
    Nelson, DJ
    BLOOD, 1998, 91 (02) : 710 - 716
  • [8] Evaluation of the immunogenicity of diaspirin cross-linked hemoglobin (DCLHb(TM)).
    Webb, EJ
    Shelbourn, TE
    Moore, EG
    MattiaGoldberg, C
    Patel, MJ
    FASEB JOURNAL, 1996, 10 (06): : 341 - 341
  • [9] Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients
    Swan, SK
    Halstenson, CE
    Collins, AJ
    Colburn, WA
    Blue, J
    Przybelski, RJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) : 918 - 923
  • [10] The effect of diaspirin cross-linked hemoglobin on coagulation in surgical patients
    OHara, JF
    Tetzlaff, JE
    Udayashankar, SV
    Connors, DF
    Bedocs, NM
    Schubert, A
    ANESTHESIOLOGY, 1997, 87 (03) : A230 - A230